SXRJ:XETRA:XETRA-iShares MSCI EMU Small Cap UCITS (EUR)

ETF | Others |

Last Closing

USD 274.7

Change

-2.10 (-0.76)%

Market Cap

USD 0.77B

Volume

3.15K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-01 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

+0.41 (+0.79%)

USD 501.76B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

+0.13 (+0.77%)

USD 191.96B
PRAJ:XETRA Amundi Index Solutions - Amund..

+0.26 (+0.97%)

USD 177.46B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

+0.21 (+0.73%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

+0.10 (+0.41%)

USD 157.79B
8R80:XETRA Amundi Index Solutions - Amund..

+0.02 (+0.01%)

USD 101.19B
JARI:XETRA Amundi Index Solutions - Amund..

+0.01 (+0.01%)

USD 100.74B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

+0.40 (+0.78%)

USD 85.64B
EUNL:XETRA iShares Core MSCI World UCITS ..

+0.19 (+0.20%)

USD 84.07B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

+1.48 (+0.27%)

USD 80.38B

ETFs Containing SXRJ:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 2.61% 26% F 33% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 2.61% 25% F 31% F
Trailing 12 Months  
Capital Gain 14.82% 43% F 48% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 14.82% 42% F 46% F
Trailing 5 Years  
Capital Gain 41.98% 58% F 61% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return 41.98% 56% F 57% F
Average Annual (5 Year Horizon)  
Capital Gain 10.10% N/A N/A 69% C-
Dividend Return 10.10% N/A N/A 67% D+
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 20.30% N/A N/A 31% F
Risk Adjusted Return 49.76% N/A N/A 57% F
Market Capitalization 0.77B 73% C 64% D

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike